CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Treated chronic hepatitis B is a good prognostic factor of diffuse large B-cell lymphoma
Jeayeon Park, Sung Won Chung, Yun Bin Lee, Hyunjae Shin, Moon Haeng Hur, Heejin Cho, Min Kyung Park, Jeonghwan Youk, Ji Yun Lee, Jeong-Ok Lee, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Tae Min Kim, Jeong-Hoon Lee
Clin Mol Hepatol. 2023;29(3):794-809.   Published online 2023 May 17    DOI: https://doi.org/10.3350/cmh.2023.0057

Excel Download

Serum albumin level at diagnosis of diffuse large B-cell lymphoma: an important simple prognostic factor
Hematological Oncology. 2015;34(4):184-192   Crossref logo
Link1 Link2 Link3

Tumor necrosis as a prognostic factor of diffuse large B-cell lymphoma treated with R-CHOP therapy
Hematological Oncology. 2017;35:295-296   Crossref logo
Link1 Link2

High Red Cell Distribution Width is an Adverse Predictive and Prognostic Factor in Patients With Diffuse Large B-Cell Lymphoma Treated With Chemoimmunotherapy
Clinical Lymphoma Myeloma and Leukemia. 2019;19(9):e551-e557   Crossref logo
Link1 Link2

P1189: ENDOTHELIAL ACTIVATION AND STRESS INDEX IS AN INDEPENDENT PROGNOSTIC FACTOR OF DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH STANDARD IMMUNOCHEMOTHERAPY
HemaSphere. 2023;7(S3):e52235b1   Crossref logo
Link1

PB2313: THE PROGNOSTIC SIGNIFICANCE OF APOPTOSIS-INDUCING FACTOR IN DIFFUSE LARGE B-CELL LYMPHOMA
HemaSphere. 2023;7(S3):e1264036   Crossref logo
Link1

Treated chronic hepatitis B is a good prognostic factor of diffuse large B-cell lymphoma
Clinical and Molecular Hepatology. 2023;29(3):794-809   Crossref logo
Link1 Link2 Link3

Expression of CD40 is a positive prognostic factor of diffuse large B-cell lymphoma treated with R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone)
OncoTargets and Therapy. 2016;3799   Crossref logo
Link1

The Endothelial Activation and Stress Index (EASIX) Score Is an Independent Prognostic Factor in Patients with Diffuse Large B-cell Lymphoma
. 2022;   Crossref logo
Link1 Link2

Poster: ABCL-300: The Relation Between Hepatitis C Infection and Cell of Origin (COO) of Diffuse Large B-Cell Lymphoma (DLBCL) and the Prognostic Value of Both Factors (Egyptian Experience)
Clinical Lymphoma Myeloma and Leukemia. 2021;21:S240   Crossref logo
Link1 Link2

ABCL-300: The Relation Between Hepatitis C Infection and Cell of Origin (COO) of Diffuse Large B-Cell Lymphoma (DLBCL) and the Prognostic Value of Both Factors (Egyptian Experience)
Clinical Lymphoma Myeloma and Leukemia. 2021;21:S388-S389   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.